vs

Side-by-side financial comparison of APTARGROUP, INC. (ATR) and Ralliant Corp (RAL). Click either name above to swap in a different company.

APTARGROUP, INC. is the larger business by last-quarter revenue ($962.7M vs $529.1M, roughly 1.8× Ralliant Corp). APTARGROUP, INC. runs the higher net margin — 7.7% vs 7.5%, a 0.2% gap on every dollar of revenue. On growth, APTARGROUP, INC. posted the faster year-over-year revenue change (13.5% vs -0.5%). Ralliant Corp produced more free cash flow last quarter ($126.6M vs $96.9M).

AptarGroup, Inc., also known as Aptar, is a United States–based global manufacturer of consumer dispensing packaging and drug delivery devices. The group has manufacturing operations in 18 countries.

ATR vs RAL — Head-to-Head

Bigger by revenue
ATR
ATR
1.8× larger
ATR
$962.7M
$529.1M
RAL
Growing faster (revenue YoY)
ATR
ATR
+14.0% gap
ATR
13.5%
-0.5%
RAL
Higher net margin
ATR
ATR
0.2% more per $
ATR
7.7%
7.5%
RAL
More free cash flow
RAL
RAL
$29.7M more FCF
RAL
$126.6M
$96.9M
ATR

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
ATR
ATR
RAL
RAL
Revenue
$962.7M
$529.1M
Net Profit
$74.3M
$39.9M
Gross Margin
50.8%
Operating Margin
11.0%
9.8%
Net Margin
7.7%
7.5%
Revenue YoY
13.5%
-0.5%
Net Profit YoY
-26.4%
-56.1%
EPS (diluted)
$1.13
$0.35

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ATR
ATR
RAL
RAL
Q4 25
$962.7M
Q3 25
$961.1M
$529.1M
Q2 25
$966.0M
$503.3M
Q1 25
$887.3M
Q4 24
$848.1M
Q3 24
$909.3M
$531.7M
Q2 24
$910.1M
$533.7M
Q1 24
$915.4M
Net Profit
ATR
ATR
RAL
RAL
Q4 25
$74.3M
Q3 25
$127.9M
$39.9M
Q2 25
$111.7M
$47.6M
Q1 25
$78.8M
Q4 24
$100.9M
Q3 24
$100.0M
$90.9M
Q2 24
$90.5M
$64.8M
Q1 24
$83.1M
Gross Margin
ATR
ATR
RAL
RAL
Q4 25
Q3 25
50.8%
Q2 25
49.3%
Q1 25
Q4 24
Q3 24
52.6%
Q2 24
51.5%
Q1 24
Operating Margin
ATR
ATR
RAL
RAL
Q4 25
11.0%
Q3 25
14.2%
9.8%
Q2 25
14.9%
11.7%
Q1 25
12.8%
Q4 24
14.2%
Q3 24
15.2%
20.9%
Q2 24
13.8%
19.7%
Q1 24
12.2%
Net Margin
ATR
ATR
RAL
RAL
Q4 25
7.7%
Q3 25
13.3%
7.5%
Q2 25
11.6%
9.5%
Q1 25
8.9%
Q4 24
11.9%
Q3 24
11.0%
17.1%
Q2 24
9.9%
12.1%
Q1 24
9.1%
EPS (diluted)
ATR
ATR
RAL
RAL
Q4 25
$1.13
Q3 25
$1.92
$0.35
Q2 25
$1.67
$0.42
Q1 25
$1.17
Q4 24
$1.48
Q3 24
$1.48
$0.81
Q2 24
$1.34
$0.57
Q1 24
$1.23

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ATR
ATR
RAL
RAL
Cash + ST InvestmentsLiquidity on hand
$409.5M
$264.2M
Total DebtLower is stronger
$1.1B
$1.1B
Stockholders' EquityBook value
$2.7B
$3.0B
Total Assets
$5.3B
$5.3B
Debt / EquityLower = less leverage
0.43×
0.39×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ATR
ATR
RAL
RAL
Q4 25
$409.5M
Q3 25
$264.8M
$264.2M
Q2 25
$169.8M
$198.6M
Q1 25
$136.8M
Q4 24
$226.2M
Q3 24
$327.9M
Q2 24
$223.9M
Q1 24
$201.1M
Total Debt
ATR
ATR
RAL
RAL
Q4 25
$1.1B
Q3 25
$546.0M
$1.1B
Q2 25
$535.1M
$1.1B
Q1 25
$561.2M
Q4 24
$688.1M
Q3 24
$822.7M
Q2 24
$681.5M
Q1 24
$680.4M
Stockholders' Equity
ATR
ATR
RAL
RAL
Q4 25
$2.7B
Q3 25
$2.8B
$3.0B
Q2 25
$2.7B
$3.0B
Q1 25
$2.5B
Q4 24
$2.5B
Q3 24
$2.5B
$4.0B
Q2 24
$2.4B
$4.0B
Q1 24
$2.3B
Total Assets
ATR
ATR
RAL
RAL
Q4 25
$5.3B
Q3 25
$5.1B
$5.3B
Q2 25
$4.9B
$5.2B
Q1 25
$4.5B
Q4 24
$4.4B
Q3 24
$4.6B
Q2 24
$4.5B
Q1 24
$4.4B
Debt / Equity
ATR
ATR
RAL
RAL
Q4 25
0.43×
Q3 25
0.20×
0.39×
Q2 25
0.20×
0.38×
Q1 25
0.22×
Q4 24
0.28×
Q3 24
0.32×
Q2 24
0.28×
Q1 24
0.29×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ATR
ATR
RAL
RAL
Operating Cash FlowLast quarter
$183.7M
$138.6M
Free Cash FlowOCF − Capex
$96.9M
$126.6M
FCF MarginFCF / Revenue
10.1%
23.9%
Capex IntensityCapex / Revenue
9.0%
2.3%
Cash ConversionOCF / Net Profit
2.47×
3.47×
TTM Free Cash FlowTrailing 4 quarters
$299.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ATR
ATR
RAL
RAL
Q4 25
$183.7M
Q3 25
$177.6M
$138.6M
Q2 25
$126.0M
Q1 25
$82.7M
Q4 24
$178.2M
Q3 24
$229.3M
Q2 24
$143.6M
Q1 24
$92.3M
Free Cash Flow
ATR
ATR
RAL
RAL
Q4 25
$96.9M
Q3 25
$114.3M
$126.6M
Q2 25
$62.5M
Q1 25
$25.9M
Q4 24
$112.2M
Q3 24
$162.7M
Q2 24
$75.4M
Q1 24
$16.7M
FCF Margin
ATR
ATR
RAL
RAL
Q4 25
10.1%
Q3 25
11.9%
23.9%
Q2 25
6.5%
Q1 25
2.9%
Q4 24
13.2%
Q3 24
17.9%
Q2 24
8.3%
Q1 24
1.8%
Capex Intensity
ATR
ATR
RAL
RAL
Q4 25
9.0%
Q3 25
6.6%
2.3%
Q2 25
6.6%
Q1 25
6.4%
Q4 24
7.8%
Q3 24
7.3%
Q2 24
7.5%
Q1 24
8.3%
Cash Conversion
ATR
ATR
RAL
RAL
Q4 25
2.47×
Q3 25
1.39×
3.47×
Q2 25
1.13×
Q1 25
1.05×
Q4 24
1.77×
Q3 24
2.29×
Q2 24
1.59×
Q1 24
1.11×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ATR
ATR

Pharma Segment$833.1M87%
Other$129.6M13%

RAL
RAL

Industrial Manufacturing$111.1M21%
Defense And Space$93.6M18%
Diversified Electronics$91.0M17%
Test And Measurement$76.8M15%
Communications$60.7M11%
Semiconductors$51.4M10%
Other Direct End Markets$44.4M8%

Related Comparisons